Countermeasures to Circadian Misalignment
C2CM
Time-restricted Feeding to Mitigate Metabolic Impairments During Circadian Misalignment
2 other identifiers
interventional
32
1 country
1
Brief Summary
Insufficient sleep and circadian misalignment are independent risk factors for the development of obesity and diabetes, yet few strategies exist to counter metabolic impairments when these behaviors are unavoidable. This project will examine whether avoiding food intake during the biological night can mitigate the impact of circadian misalignment on metabolic homeostasis in adults during simulated night shift work. Findings from this study could identify a translatable strategy to minimize metabolic diseases in populations that include anyone working nonstandard hours such as police, paramedics, firefighters, military personnel, pilots, doctors and nurses, truck drivers, and individuals with sleep disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2021
CompletedStudy Start
First participant enrolled
July 7, 2021
CompletedFirst Posted
Study publicly available on registry
July 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
July 24, 2025
July 1, 2025
5 years
May 9, 2021
July 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Insulin sensitivity-derived from glucose tolerance test
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Muscle tissue lipids-assessed by lipidomic analyses
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Secondary Outcomes (3)
24-hour circulating blood glucose levels-assessed by assay
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
24-hour circulating blood insulin levels-assessed by assay
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
24-hour circulating blood free fatty acid levels-assessed by assay
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Other Outcomes (11)
Cognitive assessments-Karolinska Sleepiness Scale
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Cognitive assessments-Positive and Negative Affect Schedule
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
Cognitive assessments- Psychomotor Vigilance Task
Change to be assessed at Day 3, Day 5, Day 31, Day 33.
- +8 more other outcomes
Study Arms (2)
Circadian misalignment (Condition A)
EXPERIMENTALParticipants will eat meals during the biological nighttime while remaining awake to mimic overnight work shifts.
Circadian misalignment with time-restricted feeding (Condition B)
EXPERIMENTALParticipants will fast during the biological nighttime while remaining awake to mimic overnight work shifts.
Interventions
Each subject will participate in both conditions (CM and CM+TRF)--one in which food is allowed during the nighttime period and one in which food will be restricted to the daytime only. Food intake will be matched across conditions and designed to keep participants weight stable.
Healthy lean subjects will undergo circadian misalignment induced using a simulated night shift-work protocol in both conditions of the study. Each condition will last approximately 6 days.
Eligibility Criteria
You may qualify if:
- old; men and women; equal numbers of women and men will be included.
- Body Mass Index (BMI) between 20.0 and 24.9 ("normal" weight).
- Physical activity history: inactive to habitual moderate physical activity level
- Sleep/wake history: habitual sleep duration between 7-9.25 hours.
- Altitude history: Potential subjects must have lived at Denver altitude or higher for at least 3 months prior to inpatient stay.
You may not qualify if:
- Any clinically significant medical, psychiatric, or sleep disorder
- Use of prescribed medications/supplements/illicit drugs within one month prior to study
- History of shift work in year prior to study, or travel more than one time zone in three weeks prior to study. \[NOTE: Subjects can be studied at a later date.\]
- Women with history of prior gynecological pathology, \<1 year post-partum, breast-feeding and/or pregnant.
- Non-English speakers will be excluded, as we do not have access to a translator who could rely accurate information to the participant for the consent or throughout the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Colorado State University
Fort Collins, Colorado, 80523, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2021
First Posted
July 19, 2021
Study Start
July 7, 2021
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
July 24, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share